Yingfen Hsia
Overview
Explore the profile of Yingfen Hsia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
1028
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsai D, Harmon E, Goelen J, Barry H, Chen L, Hsia Y
Pharmacy (Basel)
. 2024 Aug;
12(4).
PMID: 39195858
Background: The 2019 coronavirus (COVID-19) outbreak was declared a global pandemic in March 2020. It quickly spread across all continents, causing significant social, environmental, health, and economic impacts. During the...
2.
San Francisco Ramos A, Liu Sanchez C, Bovill Rose T, Smith D, Thorn N, Galiza E, et al.
Expert Rev Vaccines
. 2024 Feb;
23(1):266-282.
PMID: 38376528
Introduction: Different COVID-19 vaccines are being utilized as boosters. This systematic review and meta-analysis aims to evaluate the reactogenicity of COVID-19 vaccines given as booster doses, according to vaccine type,...
3.
Nakabembe E, Cooper J, Amaral K, Tusubira V, Hsia Y, Abu-Raya B, et al.
EClinicalMedicine
. 2024 Feb;
69:102448.
PMID: 38333366
Background: Human Immunodeficiency Virus (HIV)-exposed uninfected (HEU) infants have a higher burden of infectious diseases related morbidity and mortality compared with HIV-unexposed uninfected (HUU). Immunization of pregnant women living with...
4.
Patterson L, Berry E, Parsons C, Clarke B, Little A, Beggs J, et al.
BMC Pregnancy Childbirth
. 2023 Sep;
23(1):640.
PMID: 37674175
Since April 2021, COVID-19 vaccines have been recommended for pregnant women. Despite this, COVID-19 vaccine uptake in this group is low compared to the non-pregnant population of childbearing age. Our...
5.
Chan A, Yuen A, Tsai D, Lau W, Jani Y, Hsia Y, et al.
Nat Commun
. 2023 Aug;
14(1):5005.
PMID: 37591833
Recent studies raised concerns about the increasing use of gabapentinoids in different countries. With their potential for misuse and addiction, understanding the global consumption of gabapentinoids will offer us a...
6.
OSullivan C, Tsai D, Wu I, Boselli E, Hughes C, Padmanabhan D, et al.
BMC Infect Dis
. 2023 Jun;
23(1):441.
PMID: 37386442
Introduction: Neonatal sepsis is a major cause of health loss and mortality worldwide. Without proper treatment, neonatal sepsis can quickly develop into multisystem organ failure. However, the signs of neonatal...
7.
Vazouras K, Jackson C, Folgori L, Anastasiou-Katsiardani A, Hsia Y, Basmaci R
BMC Infect Dis
. 2023 Jun;
23(1):400.
PMID: 37308821
Background: The aim of this study was to define a set of urinary tract infections (UTIs)-specific quality indicators for appropriate prescribing in children and evaluate clinical practices in a district...
8.
Chan A, Ma T, Lau W, Ip P, Coghill D, Gao L, et al.
EClinicalMedicine
. 2023 May;
58:101780.
PMID: 37181411
Background: Timely recognition and appropriate treatment of attention-deficit/hyperactivity disorder (ADHD) are essential to enhance long-term outcomes of individuals with ADHD. This study aimed to evaluate the multinational trends and patterns...
9.
Ding Y, Hsia Y, OSullivan C, Wang Y, Heath P
Pediatr Infect Dis J
. 2022 Dec;
42(1):e15-e17.
PMID: 36476529
New studies of Group B Streptococcus (GBS) in infants <3 months of age in China have been published since our previous systematic review and meta-analysis. Using the same methodology, we...
10.
Sutton N, San Francisco Ramos A, Beales E, Smith D, Ikram S, Galiza E, et al.
Expert Rev Vaccines
. 2022 Jul;
21(9):1301-1318.
PMID: 35796029
Objectives: A number of vaccines have now been developed against COVID-19. Differences in reactogenicity and safety profiles according to the vaccine technologies employed are becoming apparent from clinical trials. Methods:...